Sept 28 (Reuters) – The U.S. Food and Drug Administration on
Wednesday approved Medtronic Plc’s “artificial pancreas”
designed to automatically deliver the right dose of insulin to
patients with…
The post UPDATE 1-U.S. FDA approves Medtronic’s ‘artificial pancreas’ for diabetes appeared first on NASDAQ.